BridgeMD
Prevention study for Radiotherapy Side Effect
Official title Photobiomodulation Therapy in the Prevention and Management of Radiotherapy-induced Vaginal Toxicity
ClinicalTrials.gov ID: NCT05165056
What this study is testing
- What it's testing
- This study aims to investigate the effectiveness of photobiomodulation therapy (PBMT) in the prevention and management of radiotherapy-induced vaginal toxicity (RIVT). Therefore, we hypothesize that PBMT can reduce the severity of RIVT in gynecological cancer patients, increasing the patient's QoL and sexual functioning.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only
You may be able to join if
- Diagnosed with endometrial cancer
- Scheduled for external beam radiotherapy (EBRT), intracavitary brachytherapy (BT), or a combination
- Age ≥ 18 years
- Able to comply to the study protocol
- Able to sign written informed consent
You likely can't join if
- Metastatic disease
- Pregnancy
- Diagnosis of vaginal stenosis before radiotherapy (RT)
- Previous pelvic tumor or pelvic RT
- Interruption of RT for more than five sessions
- Severe psychological disorder or dementia.
See the full eligibility criteria
- Diagnosed with endometrial cancer
- Scheduled for external beam radiotherapy (EBRT), intracavitary brachytherapy (BT), or a combination
- Age ≥ 18 years
- Able to comply to the study protocol
- Able to sign written informed consent
- Metastatic disease
- Pregnancy
- Diagnosis of vaginal stenosis before radiotherapy (RT)
- Previous pelvic tumor or pelvic RT
- Interruption of RT for more than five sessions
- Severe psychological disorder or dementia.
- Inability to speak and understand Dutch
- Substance abuse patients or patients with medical, psychological or social conditions that may interfere with the patient's participation in the study or evaluation of the study results as judged by the investigator
- Any condition that is unstable or could affect the safety of the patient and their compliance in the study as judged by the investigator
The study team makes the final eligibility decision.
Where it's taking place
- Genk, Limburg, Belgium
- Hasselt, Limburg, Belgium
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Genk, Limburg, Belgium; Hasselt, Limburg, Belgium. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.